Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement

• Status: Recruiting
• Trial end date: 2022-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The main objective of this study is to evaluate the effectiveness of the association of PENG and LFCN blocks on the quality of recovery 24 hours after total hip replacement surgery.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
• Treatments: Pharmaceutical Solutions; Ropivacaine

Criteria

Inclusion Criteria:

• Patients over 18 years old undergoing a total hip replacement surgery

Exclusion Criteria:

• Contraindication to regional anesthesia (allergy to local anesthetics, severe coagulopathy, infection in the designated area, pre-existing neuropathy in the obturator or femoral territory)

• Contraindication to spinal anesthesia

• Patient's refusal or inability to consent

• Opioid use on a regular basis pre-operatively

• Inability to communicate with medical team or research team

• Inability to understand the items of the multiple forms